Generic Products. In the event that any Third Party that is not a Sublicensee of KHK sells a Generic product for use in the Field in any country in the Territory in which a Licensed Product is then being sold by KHK then, during any Calendar Quarter in which sales of the Generic product by such Third Parties are equal to or greater than [***] in such country for the preceding Calendar Quarter, the applicable royalties in effect with respect
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Dicerna Pharmaceuticals Inc), Research Collaboration and License Agreement (Dicerna Pharmaceuticals Inc), Research Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)